美国新生儿法洛四联症住院管理模式的变迁
基于PHIS数据库2010至2019年6021例0至1月龄法洛四联症(ToF)住院新生儿,34%接受干预(60%根治术、31%体肺分流、9%经皮支架),各干预组院内死亡率3%至6%无差异;十年间干预比例未变,但根治术与支架增多、分流减少,并存在显著地区差异。
要点
- 34%的ToF新生儿接受干预,其中根治术占60%、体肺分流占31%、经皮支架占9%。
- 根治术、分流、支架的院内死亡率分别为6%、6%、3%,组间无显著差异(P=.446)。
- 十年间干预比例不变,但根治术(52%→69%)与支架(1%→16%)增加、分流(47%→15%)减少。
核心结论
- 多数ToF住院新生儿未接受干预即出院,超过三分之一接受干预且院内死亡率为3%至6%。
- 过去十年干预比例未变,但干预类型已改变,且存在显著地区差异。
研究设计与样本
- 回顾性数据库研究,使用PHIS数据库纳入2010至2019年0至1月龄ToF住院患儿共6021例,按2010至2014年(era 1)与2015至2019年(era 2)分期。
主要发现
- 6021例中2030例(34%)接受干预:60%根治术、31%体肺分流、9%经皮支架。
- 未干预队列院内死亡率为9%;根治术、分流、支架组分别为6%、6%、3%(P=.446)。
- 干预总体在西部最常见(36% vs 其他地区平均33.5%,P=.075),未干预在中西部最常见(69% vs 65%,P=.075)。
- 根治术在东北部最常见(76% vs 57%,P<.001),分流在中西部最常见(39% vs 28%,P<.001),支架在南部最常见(11% vs 7%,P=.083)。
- era 1至era 2:根治术由52%增至69%(P<.001),支架由1%增至16%(P<.001),分流由47%降至15%(P<.001)。
关键数值与推荐
- 干预类型包括根治术、体肺分流、右心室流出道和/或动脉导管未闭经皮支架。
- 地区差异比较的参照为其他地区平均值,仅报告P值未报告置信区间。
临床怎么用
- 对ToF新生儿决策干预方式时,可参考本研究中根治术、分流与支架的院内死亡率相近(3%至6%)及地区实践差异。
- 应关注十年间支架使用增加与分流减少的趋势,结合本中心条件个体化选择干预方式。
局限性
- 使用行政编码数据库,干预识别依赖ICD编码,可能存在编码偏倚。
- 为回顾性观察性研究,地区与时代比较为描述性,未报告置信区间。
- 干预记录于本次住院期间,不一定在新生儿期完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study describes the evolving in-hospital management strategies for neonates who are diagnosed with tetralogy of Fallot (ToF). METHODS: The Pediatric Health Information System (PHIS) database was used to identify admitted patients aged 0 to 1 month old with ToF from 2010 through 2019; era 1, 2010 through 2014; and era 2, 2015 through 2019. International Classification of Diseases codes were used to identify related interventions that occurred during this admission but not necessarily as a neonate: full repair, systemic-to-pulmonary shunt, and percutaneous stent in the right ventricular outflow tract and/or patent ductus arteriosus. RESULTS: Among 6021 neonates diagnosed with ToF, 2030 (34%) underwent an intervention: 60% had total repair, 31% systemic-to-pulmonary shunt, and 9% percutaneous stent. In the no-intervention cohort, in-hospital mortality was 9%. In-hospital mortality between repair (6%), shunt (6%), and stent (3%) patients (P = .446) did not differ. Regarding regional practices, no intervention was most frequently used in the Midwest (69% vs 65% average for all other regions [avg], P = .075) while interventions overall were performed most frequently in the West (36% vs 33.5% avg, P = .075). Among the interventions, full repair was most frequent in the Northeast (76% vs 57% avg, P < .001), shunt was most frequent in the Midwest (39% vs 28% avg, P < .001), and stent was most frequent in the South (11% vs 7% avg, P = .083). Between eras 1 and 2, the type of intervention changed: full repair (52% vs 69%, P < .001) and stent (1% vs 16%, P < .001) increased, while shunt decreased (47% vs 15%, P < .001). CONCLUSIONS: Although most neonates admitted with ToF are discharged with no intervention, more than one-third undergo some intervention with a 3% to 6% mortality. The proportion of these patients who undergo an intervention is unchanged during the past decade, but the types of intervention have changed, and significant regional differences exist.
引用
- Thangappan K, Fatuzzo S, Zafar F, et al. Management of Neonates Admitted With Tetralogy of Fallot: Changing Patterns Across the United States. Ann Thorac Surg. 2021. PMID: 34600902. doi:10.1016/j.athoracsur.2021.08.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。